Neoadjuvant Anbenitamab and HB1801 in <i>ERBB2</i> -Positive Breast Cancer

Junjie Li, Tong Liu, Ke-Da Yu, Huawei Yang, Zhen Huang, Yi Zeng, Peng Ji, Xiaoke Hou, Chunping Liu, Yiwen Zhang, Nanlin Li, Zhong Ouyang, Xiaobo Wu, Xiaorong Bai, Yanxiang Guo, Guohui Han, Shien Cui, Zhijun Zhu, Yu Zhang, Xiaobo Hu, Xiaopeng Ma, Peifen Fu, Jinhai Zhu, Yuan Dong, Tao Wu, Hongyan Jia, Fei Xu, Yu Ren, Jianyun Nie, Dai Bing, Qiang Mu, Tao Sun, Jing Luo, Zhenchuan Song, Xiangshun Kong, Hao Zhang, Zhiyong Wu, Zhihong Wang, Dong Song, Haiquan Jia, Wei Tao, Pingming Fan, Fan Yao, Chen Ru, Guie Lai, Xin Zhou, Taolang Li, Chao Deng, Xuemei Jiang, Xiaochun Wang, Jingfen Wang, Dun Xiong, Shuqun Zhang, Hongwei Yang, Yongzhong Yao, Guobing Yin, Guangyu Yao, Li Zhou, Shu Wang, Zhigang Yu, Yang Yu, Ye Lv, Hesheng Qian, Huiping Li, Wenhui Guo, Wei Huang, Silong Xiang, Kai Zou, Hang He, Lei Fan, Zhi-Ming Shao, Unknown

Open source

DOI: 10.1001/jamaoncol.2026.3329
Published: 2026-09-03
Container: JAMA Oncology
Publisher: American Medical Association (AMA)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamaoncol.2026.3329,
  title = {Neoadjuvant Anbenitamab and HB1801 in
                    <i>ERBB2</i>
                    -Positive Breast Cancer},
  author = {Junjie Li and Tong Liu and Ke-Da Yu and Huawei Yang and Zhen Huang and Yi Zeng and Peng Ji and Xiaoke Hou and Chunping Liu and Yiwen Zhang and Nanlin Li and Zhong Ouyang and Xiaobo Wu and Xiaorong Bai and Yanxiang Guo and Guohui Han and Shien Cui and Zhijun Zhu and Yu Zhang and Xiaobo Hu and Xiaopeng Ma and Peifen Fu and Jinhai Zhu and Yuan Dong and Tao Wu and Hongyan Jia and Fei Xu and Yu Ren and Jianyun Nie and Dai Bing and Qiang Mu and Tao Sun and Jing Luo and Zhenchuan Song and Xiangshun Kong and Hao Zhang and Zhiyong Wu and Zhihong Wang and Dong Song and Haiquan Jia and Wei Tao and Pingming Fan and Fan Yao and Chen Ru and Guie Lai and Xin Zhou and Taolang Li and Chao Deng and Xuemei Jiang and Xiaochun Wang and Jingfen Wang and Dun Xiong and Shuqun Zhang and Hongwei Yang and Yongzhong Yao and Guobing Yin and Guangyu Yao and Li Zhou and Shu Wang and Zhigang Yu and Yang Yu and Ye Lv and Hesheng Qian and Huiping Li and Wenhui Guo and Wei Huang and Silong Xiang and Kai Zou and Hang He and Lei Fan and Zhi-Ming Shao and Unknown},
  year = {2026},
  journal = {JAMA Oncology},
  doi = {10.1001/jamaoncol.2026.3329},
  url = {https://doi.org/10.1001/jamaoncol.2026.3329}
}

RIS

TY  - JOUR
TI  - Neoadjuvant Anbenitamab and HB1801 in
                    <i>ERBB2</i>
                    -Positive Breast Cancer
AU  - Junjie Li
AU  - Tong Liu
AU  - Ke-Da Yu
AU  - Huawei Yang
AU  - Zhen Huang
AU  - Yi Zeng
AU  - Peng Ji
AU  - Xiaoke Hou
AU  - Chunping Liu
AU  - Yiwen Zhang
AU  - Nanlin Li
AU  - Zhong Ouyang
AU  - Xiaobo Wu
AU  - Xiaorong Bai
AU  - Yanxiang Guo
AU  - Guohui Han
AU  - Shien Cui
AU  - Zhijun Zhu
AU  - Yu Zhang
AU  - Xiaobo Hu
AU  - Xiaopeng Ma
AU  - Peifen Fu
AU  - Jinhai Zhu
AU  - Yuan Dong
AU  - Tao Wu
AU  - Hongyan Jia
AU  - Fei Xu
AU  - Yu Ren
AU  - Jianyun Nie
AU  - Dai Bing
AU  - Qiang Mu
AU  - Tao Sun
AU  - Jing Luo
AU  - Zhenchuan Song
AU  - Xiangshun Kong
AU  - Hao Zhang
AU  - Zhiyong Wu
AU  - Zhihong Wang
AU  - Dong Song
AU  - Haiquan Jia
AU  - Wei Tao
AU  - Pingming Fan
AU  - Fan Yao
AU  - Chen Ru
AU  - Guie Lai
AU  - Xin Zhou
AU  - Taolang Li
AU  - Chao Deng
AU  - Xuemei Jiang
AU  - Xiaochun Wang
AU  - Jingfen Wang
AU  - Dun Xiong
AU  - Shuqun Zhang
AU  - Hongwei Yang
AU  - Yongzhong Yao
AU  - Guobing Yin
AU  - Guangyu Yao
AU  - Li Zhou
AU  - Shu Wang
AU  - Zhigang Yu
AU  - Yang Yu
AU  - Ye Lv
AU  - Hesheng Qian
AU  - Huiping Li
AU  - Wenhui Guo
AU  - Wei Huang
AU  - Silong Xiang
AU  - Kai Zou
AU  - Hang He
AU  - Lei Fan
AU  - Zhi-Ming Shao
AU  - Unknown
PY  - 2026
JO  - JAMA Oncology
DO  - 10.1001/jamaoncol.2026.3329
UR  - https://doi.org/10.1001/jamaoncol.2026.3329
ER  -

APA

Li, J., Liu, T., Yu, K., Yang, H., Huang, Z., Zeng, Y., Ji, P., Hou, X., Liu, C., Zhang, Y., Li, N., Ouyang, Z., Wu, X., Bai, X., Guo, Y., Han, G., Cui, S., Zhu, Z., Zhang, Y., Hu, X., Ma, X., Fu, P., Zhu, J., Dong, Y., Wu, T., Jia, H., Xu, F., Ren, Y., Nie, J., Bing, D., Mu, Q., Sun, T., Luo, J., Song, Z., Kong, X., Zhang, H., Wu, Z., Wang, Z., Song, D., Jia, H., Tao, W., Fan, P., Yao, F., Ru, C., Lai, G., Zhou, X., Li, T., Deng, C., Jiang, X., Wang, X., Wang, J., Xiong, D., Zhang, S., Yang, H., Yao, Y., Yin, G., Yao, G., Zhou, L., Wang, S., Yu, Z., Yu, Y., Lv, Y., Qian, H., Li, H., Guo, W., Huang, W., Xiang, S., Zou, K., He, H., Fan, L., Shao, Z., & Unknown (2026). Neoadjuvant Anbenitamab and HB1801 in <i>ERBB2</i> -Positive Breast Cancer. JAMA Oncology. https://doi.org/10.1001/jamaoncol.2026.3329

Source records

crossref · retrieved 2026-09-26T01:23:08.680Z